Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ASPIRA WOMEN'S HEALTH INC.

(AWH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Sector Update: Health Care Stocks Mixed in Afternoon Trade

07/08/2021 | 01:36pm EDT


ę MT Newswires 2021
All news about ASPIRA WOMEN'S HEALTH INC.
09/21Aspira Women's Health Inc. to Present at the Cantor Fitzgerald Virtual Global Healthcar..
GL
09/20ASPIRA WOMEN'S HEALTH INC.(NASDAQCM : AWH) dropped from S&P Healthcare Equipment Select In..
CI
09/09ASPIRA WOMEN HEALTH : Kicks Off Ovarian Cancer Awareness Month by Further Establishing Its..
AQ
08/12ASPIRA : Q2 Earnings Snapshot
AQ
08/12ASPIRA WOMEN HEALTH : Q2 Loss Widens Even as Revenue Jumps
MT
08/12ASPIRA WOMEN HEALTH : HEALTH INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
08/12ASPIRA WOMEN HEALTH : Earnings Flash (AWH) ASPIRA WOMEN'S HEALTH Posts Q2 Revenue $1.8M, v..
MT
08/12ASPIRA WOMEN HEALTH : Reports Second Quarter 2021 Financial Results (Form 8-K)
PU
08/12ASPIRA WOMEN'S HEALTH INC. : Results of Operations and Financial Condition, Financial Stat..
AQ
08/12Aspira Women's Health Reports Second Quarter 2021 Financial Results
GL
More news
Analyst Recommendations on ASPIRA WOMEN'S HEALTH INC.
More recommendations
Financials (USD)
Sales 2021 7,15 M - -
Net income 2021 -26,7 M - -
Net cash 2021 55,0 M - -
P/E ratio 2021 -12,5x
Yield 2021 -
Capitalization 359 M 359 M -
EV / Sales 2021 42,5x
EV / Sales 2022 25,1x
Nbr of Employees 35
Free-Float 52,0%
Chart ASPIRA WOMEN'S HEALTH INC.
Duration : Period :
Aspira Women's Health Inc. Technical Analysis Chart | AWH | US04537Y1091 | MarketScreener
Technical analysis trends ASPIRA WOMEN'S HEALTH INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 2
Last Close Price 3,20 $
Average target price 12,00 $
Spread / Average Target 275%
EPS Revisions
Managers and Directors
Valerie Barber Palmieri President, Chief Executive Officer & Director
Robert Beechey Chief Financial Officer
James T. LaFrance Chairman
Lesley Northrop Chief Scientific Officer
Justin DeGrazia Senior Director-Research & Development
Sector and Competitors